TrialFrontiers in immunology2025

Efficacy and safety of SMET12 in combination with toripalimab and chemotherapy in advanced non-small-cell lung cancer patients tested positive for EGFR protein who are treatment-naïve or harbor acquired resistance to standard therapy: a phase 2, multi-cohort clinical trial.

Jinghui Lin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.